ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 47 filers reported holding ALLENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,000 | -47.1% | 37,613 | +26.1% | 0.00% | – |
| Q4 2021 | $17,000 | -59.5% | 29,825 | -36.5% | 0.00% | – |
| Q3 2021 | $42,000 | -32.3% | 46,975 | -1.4% | 0.00% | – |
| Q2 2021 | $62,000 | +138.5% | 47,630 | +192.8% | 0.00% | – |
| Q2 2020 | $26,000 | +23.8% | 16,268 | -24.0% | 0.00% | – |
| Q1 2020 | $21,000 | -44.7% | 21,402 | +53.5% | 0.00% | – |
| Q4 2019 | $38,000 | -36.7% | 13,947 | +27.1% | 0.00% | – |
| Q4 2018 | $60,000 | -48.3% | 10,970 | +1.8% | 0.00% | – |
| Q3 2018 | $116,000 | -6.5% | 10,776 | -4.3% | 0.00% | – |
| Q1 2018 | $124,000 | – | 11,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $20,493,000 | 82.81% |
| Pharmstandard International S.A. | 1,037,267 | $10,435,000 | 10.73% |
| Partner Investment Management, L.P. | 575,407 | $4,724,000 | 5.44% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $33,504,000 | 5.43% |
| TRV GP II, LLC | 2,790,964 | $28,077,000 | 5.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 325,000 | $3,270,000 | 0.38% |
| PFM Health Sciences, LP | 1,464,204 | $13,255,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 605,100 | $6,087,000 | 0.24% |
| Perceptive Advisors | 250,000 | $2,515,000 | 0.08% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 18,288 | $259,000 | 0.07% |